365 related articles for article (PubMed ID: 29886242)
61. Study on the association between environmental cadmium exposure, cytochrome P450-mediated 20-HETE, heme-oxygenase-1 polymorphism and hypertension in Thai population residing in a malaria endemic areas with cadmium pollution.
Boonprasert K; Ruengweerayut R; Satarug S; Na-Bangchang K
Environ Toxicol Pharmacol; 2011 May; 31(3):416-26. PubMed ID: 21787712
[TBL] [Abstract][Full Text] [Related]
62. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis.
Yamaguchi N; Kawaguchi K; Yamamoto N
Eur J Pharmacol; 2009 Oct; 620(1-3):71-7. PubMed ID: 19686729
[TBL] [Abstract][Full Text] [Related]
63. The benefits of angiotensin II receptor blockers in patients with renal insufficiency or failure.
Venkata C; Ram S; Fierro G
Am J Ther; 1998 Mar; 5(2):101-5. PubMed ID: 10099045
[TBL] [Abstract][Full Text] [Related]
64. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Sedláková L; Kikerlová S; Husková Z; Červenková L; Chábová VČ; Zicha J; Falck JR; Imig JD; Kompanowska-Jezierska E; Sadowski J; Krátký V; Červenka L; Kopkan L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054426
[TBL] [Abstract][Full Text] [Related]
65. Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice.
Toth P; Csiszar A; Tucsek Z; Sosnowska D; Gautam T; Koller A; Schwartzman ML; Sonntag WE; Ungvari Z
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(12):H1698-708. PubMed ID: 24097425
[TBL] [Abstract][Full Text] [Related]
66. Cytochrome P450-dependent arachidonic acid metabolites, 19- and 20-hydroxyeicosatetraenoic acids, enhance sodium-potassium ATPase activity in vascular smooth muscle.
Escalante B; Sessa WC; Falck JR; Yadagiri P; Schwartzman ML
J Cardiovasc Pharmacol; 1990 Sep; 16(3):438-43. PubMed ID: 1700215
[TBL] [Abstract][Full Text] [Related]
67. Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney.
Sporková A; Čertíková Chábová V; Doleželová Š; Jíchová Š; Kopkan L; Vaňourková Z; Kompanowska-Jezierska E; Sadowski J; Maxová H; Červenka L
Am J Med Sci; 2017 Jun; 353(6):568-579. PubMed ID: 28641720
[TBL] [Abstract][Full Text] [Related]
68. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels.
Harder DR; Gebremedhin D; Narayanan J; Jefcoat C; Falck JR; Campbell WB; Roman R
Am J Physiol; 1994 May; 266(5 Pt 2):H2098-107. PubMed ID: 8203608
[TBL] [Abstract][Full Text] [Related]
69. Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?
Fava C; Ricci M; Melander O; Minuz P
Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):75-85. PubMed ID: 22173545
[TBL] [Abstract][Full Text] [Related]
70. Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy.
Wang MH; Zand BA; Nasjletti A; Laniado-Schwartzman M
Am J Physiol Regul Integr Comp Physiol; 2002 Feb; 282(2):R383-9. PubMed ID: 11792647
[TBL] [Abstract][Full Text] [Related]
71. [Progress of studies in 20-hydroxyeicosatetraenoic acid on vascular endothelium].
Li H; Zhu Y
Sheng Li Ke Xue Jin Zhan; 2013 Feb; 44(1):1-5. PubMed ID: 23671992
[TBL] [Abstract][Full Text] [Related]
72. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue.
Harder DR; Lange AR; Gebremedhin D; Birks EK; Roman RJ
J Vasc Res; 1997; 34(3):237-43. PubMed ID: 9226306
[TBL] [Abstract][Full Text] [Related]
73. Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.
Wang JS; Singh H; Zhang F; Ishizuka T; Deng H; Kemp R; Wolin MS; Hintze TH; Abraham NG; Nasjletti A; Laniado-Schwartzman M
Circ Res; 2006 Apr; 98(7):962-9. PubMed ID: 16543501
[TBL] [Abstract][Full Text] [Related]
74. Arachidonic acid cytochrome P450 4F2 in hypertension: what can we learn from a transgenic mouse model??
Cai Y
Kidney Int; 2009 Jun; 75(12):1253-1254. PubMed ID: 19483747
[TBL] [Abstract][Full Text] [Related]
75. Role of prostanoids and 20-HETE in mediating oxygen-induced constriction of skeletal muscle resistance arteries.
Frisbee JC; Krishna UM; Falck JR; Lombard JH
Microvasc Res; 2001 Nov; 62(3):271-83. PubMed ID: 11678630
[TBL] [Abstract][Full Text] [Related]
76. Arachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevance.
Capdevila JH; Wang W; Falck JR
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():40-9. PubMed ID: 25986599
[TBL] [Abstract][Full Text] [Related]
77. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans.
Ward NC; Rivera J; Hodgson J; Puddey IB; Beilin LJ; Falck JR; Croft KD
Circulation; 2004 Jul; 110(4):438-43. PubMed ID: 15262846
[TBL] [Abstract][Full Text] [Related]
78. Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension.
Sarkis A; Lopez B; Roman RJ
Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):205-14. PubMed ID: 15202615
[TBL] [Abstract][Full Text] [Related]
79. The Malaria-High Blood Pressure Hypothesis: Revisited.
Nwokocha CR; Bafor EE; Ajayi OI; Ebeigbe AB
Am J Hypertens; 2020 Aug; 33(8):695-702. PubMed ID: 32211753
[TBL] [Abstract][Full Text] [Related]
80. The role of 20-HETE in cardiovascular diseases and its risk factors.
Waldman M; Peterson SJ; Arad M; Hochhauser E
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():108-17. PubMed ID: 27287720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
